PortfoliosLab logoPortfoliosLab logo
TTAN vs. PVLA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TTAN vs. PVLA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ServiceTitan, Inc (TTAN) and Palvella Therapeutics, Inc (PVLA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TTAN achieves a -39.73% return, which is significantly lower than PVLA's 13.38% return.


TTAN

1D
2.59%
1M
1.61%
YTD
-39.73%
6M
-41.59%
1Y
-38.26%
3Y*
5Y*
10Y*

PVLA

1D
-0.13%
1M
4.11%
YTD
13.38%
6M
18.36%
1Y
426.53%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TTAN vs. PVLA - Yearly Performance Comparison


2026 (YTD)20252024
TTAN
ServiceTitan, Inc
-39.73%3.53%2.87%
PVLA
Palvella Therapeutics, Inc
13.38%772.25%-8.27%

Correlation

The correlation between TTAN and PVLA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Dec 16, 2024

0.07

Fundamentals

Market Cap

TTAN:

$6.10B

PVLA:

$1.34B

EPS

TTAN:

-$246.61

PVLA:

-$3.75

PB Ratio

TTAN:

0.00

PVLA:

47.72

Total Revenue (TTM)

TTAN:

$269.57B

PVLA:

$0.00

Gross Profit (TTM)

TTAN:

$194.32B

PVLA:

$0.00

EBITDA (TTM)

TTAN:

-$25.80B

PVLA:

-$14.75M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TTAN vs. PVLA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TTAN
TTAN Risk / Return Rank: 1313
Overall Rank
TTAN Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
TTAN Sortino Ratio Rank: 1212
Sortino Ratio Rank
TTAN Omega Ratio Rank: 1414
Omega Ratio Rank
TTAN Calmar Ratio Rank: 1515
Calmar Ratio Rank
TTAN Martin Ratio Rank: 1313
Martin Ratio Rank

PVLA
PVLA Risk / Return Rank: 9797
Overall Rank
PVLA Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
PVLA Sortino Ratio Rank: 9797
Sortino Ratio Rank
PVLA Omega Ratio Rank: 9595
Omega Ratio Rank
PVLA Calmar Ratio Rank: 9999
Calmar Ratio Rank
PVLA Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TTAN vs. PVLA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ServiceTitan, Inc (TTAN) and Palvella Therapeutics, Inc (PVLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TTANPVLADifference
Sharpe ratioReturn per unit of total volatility

-6.07

Sortino ratioReturn per unit of downside risk

-5.43

Omega ratioGain probability vs. loss probability

0.89

1.54

-0.64

Calmar ratioReturn relative to maximum drawdown

-0.71

13.82

-14.54

Martin ratioReturn relative to average drawdown

-1.25

31.14

-32.39

TTAN vs. PVLA - Sharpe Ratio Comparison

The current TTAN Sharpe Ratio is -0.75, which is lower than the PVLA Sharpe Ratio of 5.32. The chart below compares the historical Sharpe Ratios of TTAN and PVLA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TTAN vs. PVLA - Drawdown Comparison

The maximum TTAN drawdown since its inception was -57.26%, which is greater than PVLA's maximum drawdown of -31.48%. Use the drawdown chart below to compare losses from any high point for TTAN and PVLA.


Loading charts...

Drawdown Indicators


TTANPVLADifference

Max Drawdown

Largest peak-to-trough decline

-57.26%

-31.48%

-25.78%

Max Drawdown (1Y)

Largest decline over 1 year

-53.78%

-31.11%

-22.67%

Current Drawdown

Current decline from peak

-50.38%

-19.99%

-30.39%

Average Drawdown

Average peak-to-trough decline

-24.02%

-11.16%

-12.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.73%

13.79%

+16.94%

Volatility

TTAN vs. PVLA - Volatility Comparison

ServiceTitan, Inc (TTAN) and Palvella Therapeutics, Inc (PVLA) have volatilities of 19.50% and 19.68%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TTANPVLADifference

Volatility (1M)

Calculated over the trailing 1-month period

19.50%

19.68%

-0.18%

Volatility (6M)

Calculated over the trailing 6-month period

42.13%

61.91%

-19.78%

Volatility (1Y)

Calculated over the trailing 1-year period

51.38%

80.85%

-29.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.68%

82.11%

-31.43%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

50.68%

82.11%

-31.43%

Dividends

TTAN vs. PVLA - Dividend Comparison

Neither TTAN nor PVLA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TTAN vs. PVLA - Financials Comparison

This section allows you to compare key financial metrics between ServiceTitan, Inc and Palvella Therapeutics, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B250.00BJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
268.82B
0
(TTAN) Total Revenue
(PVLA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TTAN and PVLA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PVLA has higher volatility (19.68%) compared to TTAN (19.50%). In terms of maximum drawdown, TTAN dropped -57.26% vs PVLA's -31.48%.

PVLA currently has the higher Sharpe Ratio (5.32 vs -0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TTAN and PVLA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer